Categories
Latest Industry Intelligence
As the world is rocked by one of the greatest healthcare challenges in living memory, [...]
Luis Valente, CEO & Co-Founder of iLoF, has been recognized by Forbes as one of [...]
…manufacturing a new class of mRNA-based vaccines. The investments in this proprietary platform have enabled Moderna to expeditiously create, manufacture and clinically develop mRNA-1273 to potentially address the current COVID-19…
…which the ‘Spike’ protein recognises human cells is central to the development of antiviral therapies and vaccines to treat COVID-19. In this breakthrough study, the research groups in Bristol’s Faculty…
…the SARS-CoV-2 virus their immune system is pre-trained and ready to attack it. Adenoviruses have been used for many years to make vaccines, and these are always tested to very…
Aerogen has released details of a collaborative effort to support global pharmaceutical companies developing COVID-19 vaccines and therapies. To date, more than ten million patients globally have been treated safely…
…number of volunteers that are included in the characterisation study. The government has also secured the first three slots to test vaccines using hVIVO’s COVID-19 challenge study, which is expected…
…first participants enrolled at the new NIHR research centre in Blackpool five days later. Brought to the UK in collaboration with the UK Government’s Vaccines Taskforce, the Novavax trial is…
…many as 40 US sites, is being conducted in collaboration with the NIH’s public-private partnership Accelerating COVID-19 Therapeutic Innovations and Vaccines (ACTIV) program. “The ACTIV-5/BET study aims to streamline the…
…of vaccines are destroyed each year due to improper storage, transportation, and distribution. If similar issues impact the supply of novel COVID-19 vaccines, the industry at large could face epic…
…processes to help create vaccines, therapeutics and drugs. From research stage to clinical trials DDW’s main focus is turning science into business. It covers the scientific and commercial process involved…
Research to end the COVID-19 pandemic has focused on both development of vaccines to prevent infection and therapeutic strategies to treat those already infected. Octet® systems are furthering the understanding…
Menu ≡ ╳ 
